AI assistant
Sending…
RESMED INC — Director's Dealing 2010
Mar 11, 2010
30071_dirs_2010-03-11_88ca9cbc-0153-465e-bdd9-e1de1cda6177.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-03-10
Reporting Person: Gallahue Kieran (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-10 | ResMed Common Stock | M | 10000 | $23.885 | Acquired | 13223.897 | Direct |
| 2010-03-10 | ResMed Common Stock | S | 10000 | $60.00 | Disposed | 3223.897 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-10 | ResMed Stock Options | $23.885 | M | 10000 | Disposed | 2014-09-01 | ResMed Common Stock (10000) | Direct |
Footnotes
F1: Represents first date options became exercisable.
F2: Trade executed in accordance with 10b5-1 trading plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29